Initial combination therapy with alogliptin and pioglitazone in drug-naïve patients with type 2 diabetes (Q34237413)

31 July 2017

Initial combination therapy with alogliptin and pioglitazone in drug-naïve patients with type 2 diabetes (English)

1 reference

31 July 2017

0 references

0 references

1

Julio Rosenstock

1 reference

31 July 2017

2

Silvio E Inzucchi

1 reference

31 July 2017

Jochen Seufert

3

1 reference

31 July 2017

Penny R Fleck

series ordinal

4

1 reference

31 July 2017

Craig A Wilson

series ordinal

5

1 reference

31 July 2017

Qais Mekki

series ordinal

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

19 August 2010

1 reference

31 July 2017

1 reference

31 July 2017

33

1 reference

31 July 2017

2406-2408

1 reference

31 July 2017

11

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

31 July 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963503

New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963503

Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963503

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963503

Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963503

Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963503

Janumet: a combination product suitable for use in patients with Type 2 diabetes

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20724648

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC10-0159

1 reference

31 July 2017

0 references

1 reference

31 July 2017

1 reference